Research ArticleArticle
Increase in Bone Density in Patients with Spondyloarthritis During Anti-Tumor Necrosis Factor Therapy: 6-year Followup Study
Anne Durnez, Simon Paternotte, Jacques Fechtenbaum, Robert B.M. Landewé, Maxime Dougados, Christian Roux and Karine Briot
The Journal of Rheumatology August 2013, jrheum.121417; DOI: https://doi.org/10.3899/jrheum.121417
Anne Durnez
From Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France; Rheumatology Department, AZ Groeninge, Kortrijk, Belgium; and the University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. Dr. Durnez was supported by a EULAR grant, the Belgian Fund for Scientific Research in Rheumatology (FWRO/FRSR), and a European Calcified Tissue Society grant (ECTS); and has received fees and/or honoraria from Abbott, MSD, and Pfizer. Dr. Dougados has received consultancies, fees, and/or honoraria from Pfizer, Abbott, UCB, and Roche. Dr. Roux has received consultancies, fees, and/or honoraria from Amgen, MSD, Roche, Novartis, Servier, Lilly, and Pfizer. Dr. Briot has received consultancies, fees, and/or honoraria from Amgen, MSD, Novartis, and Lilly. A. Durnez, MD, PhD, Rheumatology Department, Cochin Hospital; Rheumatology Department, AZ Groeninge; S. Paternotte, MSc; J. Fechtenbaum, MD, PhD, Rheumatology Department, Cochin Hospital; R.B.M. Landewé, MD, PhD, University of Amsterdam; Atrium Medical Center; M. Dougados, MD; C. Roux, MD, PhD; K. Briot, MD, PhD, Rheumatology Department, Cochin Hospital. Address correspondence to Dr. K. Briot, Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France. E-mail: karine.briot@cch.aphp.fr. Accepted for publication June 11, 2013.
Simon Paternotte
From Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France; Rheumatology Department, AZ Groeninge, Kortrijk, Belgium; and the University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. Dr. Durnez was supported by a EULAR grant, the Belgian Fund for Scientific Research in Rheumatology (FWRO/FRSR), and a European Calcified Tissue Society grant (ECTS); and has received fees and/or honoraria from Abbott, MSD, and Pfizer. Dr. Dougados has received consultancies, fees, and/or honoraria from Pfizer, Abbott, UCB, and Roche. Dr. Roux has received consultancies, fees, and/or honoraria from Amgen, MSD, Roche, Novartis, Servier, Lilly, and Pfizer. Dr. Briot has received consultancies, fees, and/or honoraria from Amgen, MSD, Novartis, and Lilly. A. Durnez, MD, PhD, Rheumatology Department, Cochin Hospital; Rheumatology Department, AZ Groeninge; S. Paternotte, MSc; J. Fechtenbaum, MD, PhD, Rheumatology Department, Cochin Hospital; R.B.M. Landewé, MD, PhD, University of Amsterdam; Atrium Medical Center; M. Dougados, MD; C. Roux, MD, PhD; K. Briot, MD, PhD, Rheumatology Department, Cochin Hospital. Address correspondence to Dr. K. Briot, Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France. E-mail: karine.briot@cch.aphp.fr. Accepted for publication June 11, 2013.
Jacques Fechtenbaum
From Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France; Rheumatology Department, AZ Groeninge, Kortrijk, Belgium; and the University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. Dr. Durnez was supported by a EULAR grant, the Belgian Fund for Scientific Research in Rheumatology (FWRO/FRSR), and a European Calcified Tissue Society grant (ECTS); and has received fees and/or honoraria from Abbott, MSD, and Pfizer. Dr. Dougados has received consultancies, fees, and/or honoraria from Pfizer, Abbott, UCB, and Roche. Dr. Roux has received consultancies, fees, and/or honoraria from Amgen, MSD, Roche, Novartis, Servier, Lilly, and Pfizer. Dr. Briot has received consultancies, fees, and/or honoraria from Amgen, MSD, Novartis, and Lilly. A. Durnez, MD, PhD, Rheumatology Department, Cochin Hospital; Rheumatology Department, AZ Groeninge; S. Paternotte, MSc; J. Fechtenbaum, MD, PhD, Rheumatology Department, Cochin Hospital; R.B.M. Landewé, MD, PhD, University of Amsterdam; Atrium Medical Center; M. Dougados, MD; C. Roux, MD, PhD; K. Briot, MD, PhD, Rheumatology Department, Cochin Hospital. Address correspondence to Dr. K. Briot, Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France. E-mail: karine.briot@cch.aphp.fr. Accepted for publication June 11, 2013.
Robert B.M. Landewé
From Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France; Rheumatology Department, AZ Groeninge, Kortrijk, Belgium; and the University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. Dr. Durnez was supported by a EULAR grant, the Belgian Fund for Scientific Research in Rheumatology (FWRO/FRSR), and a European Calcified Tissue Society grant (ECTS); and has received fees and/or honoraria from Abbott, MSD, and Pfizer. Dr. Dougados has received consultancies, fees, and/or honoraria from Pfizer, Abbott, UCB, and Roche. Dr. Roux has received consultancies, fees, and/or honoraria from Amgen, MSD, Roche, Novartis, Servier, Lilly, and Pfizer. Dr. Briot has received consultancies, fees, and/or honoraria from Amgen, MSD, Novartis, and Lilly. A. Durnez, MD, PhD, Rheumatology Department, Cochin Hospital; Rheumatology Department, AZ Groeninge; S. Paternotte, MSc; J. Fechtenbaum, MD, PhD, Rheumatology Department, Cochin Hospital; R.B.M. Landewé, MD, PhD, University of Amsterdam; Atrium Medical Center; M. Dougados, MD; C. Roux, MD, PhD; K. Briot, MD, PhD, Rheumatology Department, Cochin Hospital. Address correspondence to Dr. K. Briot, Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France. E-mail: karine.briot@cch.aphp.fr. Accepted for publication June 11, 2013.
Maxime Dougados
From Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France; Rheumatology Department, AZ Groeninge, Kortrijk, Belgium; and the University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. Dr. Durnez was supported by a EULAR grant, the Belgian Fund for Scientific Research in Rheumatology (FWRO/FRSR), and a European Calcified Tissue Society grant (ECTS); and has received fees and/or honoraria from Abbott, MSD, and Pfizer. Dr. Dougados has received consultancies, fees, and/or honoraria from Pfizer, Abbott, UCB, and Roche. Dr. Roux has received consultancies, fees, and/or honoraria from Amgen, MSD, Roche, Novartis, Servier, Lilly, and Pfizer. Dr. Briot has received consultancies, fees, and/or honoraria from Amgen, MSD, Novartis, and Lilly. A. Durnez, MD, PhD, Rheumatology Department, Cochin Hospital; Rheumatology Department, AZ Groeninge; S. Paternotte, MSc; J. Fechtenbaum, MD, PhD, Rheumatology Department, Cochin Hospital; R.B.M. Landewé, MD, PhD, University of Amsterdam; Atrium Medical Center; M. Dougados, MD; C. Roux, MD, PhD; K. Briot, MD, PhD, Rheumatology Department, Cochin Hospital. Address correspondence to Dr. K. Briot, Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France. E-mail: karine.briot@cch.aphp.fr. Accepted for publication June 11, 2013.
Christian Roux
From Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France; Rheumatology Department, AZ Groeninge, Kortrijk, Belgium; and the University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. Dr. Durnez was supported by a EULAR grant, the Belgian Fund for Scientific Research in Rheumatology (FWRO/FRSR), and a European Calcified Tissue Society grant (ECTS); and has received fees and/or honoraria from Abbott, MSD, and Pfizer. Dr. Dougados has received consultancies, fees, and/or honoraria from Pfizer, Abbott, UCB, and Roche. Dr. Roux has received consultancies, fees, and/or honoraria from Amgen, MSD, Roche, Novartis, Servier, Lilly, and Pfizer. Dr. Briot has received consultancies, fees, and/or honoraria from Amgen, MSD, Novartis, and Lilly. A. Durnez, MD, PhD, Rheumatology Department, Cochin Hospital; Rheumatology Department, AZ Groeninge; S. Paternotte, MSc; J. Fechtenbaum, MD, PhD, Rheumatology Department, Cochin Hospital; R.B.M. Landewé, MD, PhD, University of Amsterdam; Atrium Medical Center; M. Dougados, MD; C. Roux, MD, PhD; K. Briot, MD, PhD, Rheumatology Department, Cochin Hospital. Address correspondence to Dr. K. Briot, Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France. E-mail: karine.briot@cch.aphp.fr. Accepted for publication June 11, 2013.
Karine Briot
From Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France; Rheumatology Department, AZ Groeninge, Kortrijk, Belgium; and the University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. Dr. Durnez was supported by a EULAR grant, the Belgian Fund for Scientific Research in Rheumatology (FWRO/FRSR), and a European Calcified Tissue Society grant (ECTS); and has received fees and/or honoraria from Abbott, MSD, and Pfizer. Dr. Dougados has received consultancies, fees, and/or honoraria from Pfizer, Abbott, UCB, and Roche. Dr. Roux has received consultancies, fees, and/or honoraria from Amgen, MSD, Roche, Novartis, Servier, Lilly, and Pfizer. Dr. Briot has received consultancies, fees, and/or honoraria from Amgen, MSD, Novartis, and Lilly. A. Durnez, MD, PhD, Rheumatology Department, Cochin Hospital; Rheumatology Department, AZ Groeninge; S. Paternotte, MSc; J. Fechtenbaum, MD, PhD, Rheumatology Department, Cochin Hospital; R.B.M. Landewé, MD, PhD, University of Amsterdam; Atrium Medical Center; M. Dougados, MD; C. Roux, MD, PhD; K. Briot, MD, PhD, Rheumatology Department, Cochin Hospital. Address correspondence to Dr. K. Briot, Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France. E-mail: karine.briot@cch.aphp.fr. Accepted for publication June 11, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Increase in Bone Density in Patients with Spondyloarthritis During Anti-Tumor Necrosis Factor Therapy: 6-year Followup Study
Anne Durnez, Simon Paternotte, Jacques Fechtenbaum, Robert B.M. Landewé, Maxime Dougados, Christian Roux, Karine Briot
The Journal of Rheumatology Aug 2013, jrheum.121417; DOI: 10.3899/jrheum.121417
Increase in Bone Density in Patients with Spondyloarthritis During Anti-Tumor Necrosis Factor Therapy: 6-year Followup Study
Anne Durnez, Simon Paternotte, Jacques Fechtenbaum, Robert B.M. Landewé, Maxime Dougados, Christian Roux, Karine Briot
The Journal of Rheumatology Aug 2013, jrheum.121417; DOI: 10.3899/jrheum.121417